LAAC and Blood Thinners: What the Data Really Show

Researchers wanted to see if closing the left atrial appendage works as well as taking blood‑thinning pills for people with an irregular heartbeat. They looked at six studies that randomly assigned patients to either the closure procedure or standard medication. The total number of volunteers was around seven thousand.

The main things they measured were death from any cause, any kind of stroke, bleeding that needed a hospital stay, and heart‑related death. Both groups had about the same risk for these outcomes. The data showed no clear difference in overall death or major bleeding.

There was a small, not‑statistically‑significant signal that the closure group might have a higher chance of the most common stroke type and a lower chance of bleeding inside the brain. When they looked at how events unfolded over time, the patterns were alike for strokes and bleeds. A method called trial sequential analysis said the studies did not gather enough information yet, meaning the proof is still weak.

Because the evidence is not strong enough, doctors keep the closure for a select group of patients rather than using it to replace pills for everyone. More large trials with longer follow‑up are needed before we can be sure it is truly better or safer.